The forecasted insulin dosage market size per capita in Canada shows a consistent growth over the period from 2024 to 2028. In 2023, the market size stood at 36.72 USD. The year-on-year variation indicates a steady increase: 1.56% from 2024 to 2025, 1.51% from 2025 to 2026, 1.46% from 2026 to 2027, and 1.38% from 2027 to 2028. The average annual growth rate (CAGR) over the forecasted five-year period (2024-2028) is approximately 1.48%.
Future trends to watch for include advancements in insulin delivery technology, potential pricing adjustments influenced by policy changes, and the impact of emerging biosimilar insulins. Additionally, increasing diabetes prevalence and healthcare innovations will likely continue to drive market growth.
